Compiled all in one place, read news articles from each of the news categories, about drugs, the pharmaceutical industry, national and international awareness causes, scientific meetings, trending stories and epgonline.org headlines.

Drug News

Added 17 hours ago Drug news

Overall survival results from PACIFIC Phase III trial of Imfinzi in unresectable stage III NSCLC.- AstraZeneca.

AstraZeneca and MedImmune, its global biologics research and development arm, announced positive overall survival (OS) results for the Phase III...

Added 17 hours ago Drug news

Phase III iLLUMINATE trial report of Imbruvica + Gazyva combination for chronic lymphocytic leukemia or small lymphocytic lymphoma.- Abbvie + Janssen Biotech

AbbVie has announced that the Phase III iLLUMINATE (PCYC-1130) trial met its primary endpoint of improvement in progression-free survival (PFS)....

Added 1 day ago Drug news

FDA approves Palynziq to reduce blood phenylalanine concentrations in adult patients with phenylketonuria (PKU).- BioMarin.

BioMarin Pharmaceutical Inc. announced that BioMarin received standard approval from the FDA for Palynziq™ (pegvaliase-pqpz) Injection to reduce blood phenylalanine...

Added 1 day ago Drug news

Retrospective effectiveness study positive for Saxenda in weight reduction.- Novo Nordisk.

People treated with Saxenda (liraglutide 3 mg) for weight management lost an average of 8.1 kg after six months in...

Added 1 day ago Drug news

NICE issues draft guidance refusing the use of Lamzede for alpha-mannosidosis.- Chiesi.

In draft guidance, the National Institute for Health and Care Excellence has announced that the size and nature of any...

Added 1 day ago Drug news

Complete response letter for N 1539 (i.v.meloxicam) for acute post surgical pain.- Recro Pharma.

Recro Pharma, Inc. announced it has received a Complete Response Letter (CRL) from the FDA Office of Drug Evaluation II...

Added 1 day ago Drug news

Arzerra fails to meet primary endpoint in phase III COMPLEMENT A+B study in indolent B-cell non-Hodgkin's lymphoma.- Genmab.

Genmab announced that topline results from the Phase III study of Arzerra (ofatumumab) plus bendamustine did not meet the primary...

Added 1 day ago Drug news

Large-scale body composition study reveals link between specific fat distributions and metabolic diseases and is published in Obesity- AMRA Medical

Specific patterns of fat distribution are linked to the presence of Coronary Heart Disease (CHD) and Type 2 Diabetes (T2D),...

Added 2 days ago Drug news

EU approves biosimilar Zessly, to treat all indications of infliximab,the reference medicine.- Sandoz.

Sandoz, announced that the European Commission (EC) has approved Zessly (infliximab) for use in Europe. Zessly is approved for use in...

Added 1 day ago Drug news

FDA approves Catasyn Advanced Technology Wound Hydrogel to treat burns and wounds.- Synedgen.

Synedgen, a company leveraging its proprietary glycomics technology platform to develop glycopolymer-based therapeutics for infectious and inflammatory conditions, announced that...

Search all news articles